Impact of temporary and involuntary suppression of hydroxyurea treatment on hematological and clinical parameters in patients with sickle cell disease . Research, Society and Development, [S. l.], v. 13, n. 1, p. e3013144727, 2024. DOI: 10.33448/rsd-v13i1.44727. Disponível em: https://ojs34.rsdjournal.org/index.php/rsd/article/view/44727. Acesso em: 28 jun. 2025.